Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer

Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma

(2019) Yan Su et al.   Cancer Medicine

Alter circulating cell‐free DNA variables in plasma of ovarian cancer patients

(2019) Zhou Yu et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Prognostic Significance of CT-Attenuation of Tumor-Adjacent Breast Adipose Tissue in Breast Cancer Patients with Surgical Resection

(2019) Jeong Won Lee et al.   Cancers

Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients

(2018) S. Valpione et al.   EUROPEAN JOURNAL OF CANCER

The value of cell-free DNA for molecular pathology

(2018) Caitlin M Stewart et al.   JOURNAL OF PATHOLOGY

Circulating cell-free DNA for non-invasive cancer management

(2018) Caitlin M. Stewart et al.   Cancer Genetics

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications

(2017) Anna-Lena Volckmar et al.   GENES CHROMOSOMES & CANCER

Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients

(2017) Chiara Bedin et al.   INTERNATIONAL JOURNAL OF CANCER

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer

(2016) Swati Kumari et al.   PATHOLOGY & ONCOLOGY RESEARCH

Alu–based cell-free DNA: a novel biomarker for screening of gastric cancer

(2016) Chen Qian et al.   Oncotarget

Clinical relevance of cell-free DNA in gastrointestinal tract malignancy

(2016) Yuan-Tzu Lan et al.   Oncotarget